Integral Historical Income Statement

IDX Stock

2.91 0.01 0.34%

Historical analysis of Integral Diagnostics income statement accounts such as Operating Income of 5.1 M or Depreciation And Amortization of 49.5 M can show how well Integral Diagnostics performed in making a profits. Evaluating Integral Diagnostics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Integral Diagnostics's future profits or losses.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Integral Diagnostics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Integral Diagnostics is a good buy for the upcoming year.

Net Income Gross Profit

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Integral Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Integral Income Statement Analysis

Integral Diagnostics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Integral Diagnostics shareholders. The income statement also shows Integral investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Integral Diagnostics Income Statement Chart

At this time, Integral Diagnostics' Interest Expense is comparatively stable compared to the past year. Depreciation And Amortization is likely to gain to about 49.5 M in 2024, despite the fact that Income Before Tax is likely to grow to (54.2 M).

Operating Income Selling General Administrative Gross Profit Other Operating Expenses Net Interest Income

Operating Income

Operating Income is the amount of profit realized from Integral Diagnostics operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Integral Diagnostics is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Integral Diagnostics minus its cost of goods sold. It is profit before Integral Diagnostics operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Integral Diagnostics. It is also known as Integral Diagnostics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Net Interest Income

The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.

Most accounts from Integral Diagnostics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Integral Diagnostics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Integral Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2021	2022	2023	2024 (projected)
Operating Income	38.4M	40.1M	5.4M	5.1M
Total Revenue	358.7M	440.1M	469.7M	238.8M

Operating Income Total Revenue

Integral Diagnostics income statement Correlations

	Interest Expense	Total Revenue	Operating Income	Income Before Tax	Depreciation And Amortization	Selling General Administrative	Gross Profit	Other Operating Expenses	Ebit	Ebitda	Total Operating Expenses	Net Income	Income Tax Expense	Net Income From Continuing Ops	Cost Of Revenue	Total Other Income Expense Net	Tax Provision	Interest Income	Minority Interest	Net Interest Income	Selling And Marketing Expenses	Reconciled Depreciation
Interest Expense		0.8	0.13	-0.49	0.95	0.82	0.7	0.96	-0.28	0.32	0.63	-0.57	0.34	-0.57	0.85	-0.82	-0.19	0.41	-0.74	-0.98	0.9	0.88
Total Revenue	0.8		0.6	-0.01	0.9	1.0	0.94	0.9	0.22	0.71	0.87	-0.12	0.64	-0.12	0.99	-0.53	0.17	0.48	-0.27	-0.76	0.9	0.89
Operating Income	0.13	0.6		0.75	0.37	0.56	0.7	0.35	0.88	0.95	0.63	0.66	0.85	0.66	0.53	0.24	0.69	0.45	0.39	-0.04	0.27	0.32
Income Before Tax	-0.49	-0.01	0.75		-0.28	-0.06	0.07	-0.33	0.97	0.65	0.02	0.99	0.44	0.99	-0.09	0.82	0.73	0.3	0.84	0.54	-0.28	-0.22
Depreciation And Amortization	0.95	0.9	0.37	-0.28		0.91	0.81	0.98	-0.04	0.54	0.73	-0.38	0.55	-0.38	0.94	-0.72	0.03	0.4	-0.6	-0.92	0.91	0.93
Selling General Administrative	0.82	1.0	0.56	-0.06	0.91		0.94	0.92	0.17	0.68	0.88	-0.16	0.6	-0.16	0.99	-0.56	0.11	0.48	-0.31	-0.78	0.91	0.89
Gross Profit	0.7	0.94	0.7	0.07	0.81	0.94		0.85	0.29	0.72	0.97	-0.05	0.77	-0.05	0.9	-0.48	0.21	0.4	-0.26	-0.61	0.72	0.69
Other Operating Expenses	0.96	0.9	0.35	-0.33	0.98	0.92	0.85		-0.09	0.49	0.8	-0.43	0.55	-0.43	0.92	-0.78	-0.06	0.37	-0.65	-0.91	0.88	0.87
Ebit	-0.28	0.22	0.88	0.97	-0.04	0.17	0.29	-0.09		0.82	0.23	0.93	0.59	0.93	0.15	0.67	0.74	0.44	0.73	0.33	-0.07	0.0
Ebitda	0.32	0.71	0.95	0.65	0.54	0.68	0.72	0.49	0.82		0.62	0.56	0.81	0.56	0.67	0.14	0.64	0.6	0.28	-0.26	0.48	0.54
Total Operating Expenses	0.63	0.87	0.63	0.02	0.73	0.88	0.97	0.8	0.23	0.62		-0.09	0.67	-0.09	0.82	-0.49	0.06	0.35	-0.26	-0.55	0.64	0.58
Net Income	-0.57	-0.12	0.66	0.99	-0.38	-0.16	-0.05	-0.43	0.93	0.56	-0.09		0.31	1.0	-0.19	0.89	0.66	0.28	0.88	0.61	-0.36	-0.3
Income Tax Expense	0.34	0.64	0.85	0.44	0.55	0.6	0.77	0.55	0.59	0.81	0.67	0.31		0.31	0.58	-0.1	0.71	0.23	-0.03	-0.24	0.32	0.4
Net Income From Continuing Ops	-0.57	-0.12	0.66	0.99	-0.38	-0.16	-0.05	-0.43	0.93	0.56	-0.09	1.0	0.31		-0.19	0.89	0.66	0.28	0.88	0.61	-0.36	-0.3
Cost Of Revenue	0.85	0.99	0.53	-0.09	0.94	0.99	0.9	0.92	0.15	0.67	0.82	-0.19	0.58	-0.19		-0.57	0.12	0.49	-0.34	-0.82	0.94	0.93
Total Other Income Expense Net	-0.82	-0.53	0.24	0.82	-0.72	-0.56	-0.48	-0.78	0.67	0.14	-0.49	0.89	-0.1	0.89	-0.57		0.44	0.09	0.9	0.82	-0.65	-0.6
Tax Provision	-0.19	0.17	0.69	0.73	0.03	0.11	0.21	-0.06	0.74	0.64	0.06	0.66	0.71	0.66	0.12	0.44		0.1	0.46	0.23	-0.06	0.08
Interest Income	0.41	0.48	0.45	0.3	0.4	0.48	0.4	0.37	0.44	0.6	0.35	0.28	0.23	0.28	0.49	0.09	0.1		0.11	-0.41	0.49	0.45
Minority Interest	-0.74	-0.27	0.39	0.84	-0.6	-0.31	-0.26	-0.65	0.73	0.28	-0.26	0.88	-0.03	0.88	-0.34	0.9	0.46	0.11		0.73	-0.44	-0.41
Net Interest Income	-0.98	-0.76	-0.04	0.54	-0.92	-0.78	-0.61	-0.91	0.33	-0.26	-0.55	0.61	-0.24	0.61	-0.82	0.82	0.23	-0.41	0.73		-0.92	-0.9
Selling And Marketing Expenses	0.9	0.9	0.27	-0.28	0.91	0.91	0.72	0.88	-0.07	0.48	0.64	-0.36	0.32	-0.36	0.94	-0.65	-0.06	0.49	-0.44	-0.92		0.97
Reconciled Depreciation	0.88	0.89	0.32	-0.22	0.93	0.89	0.69	0.87	0.0	0.54	0.58	-0.3	0.4	-0.3	0.93	-0.6	0.08	0.45	-0.41	-0.9	0.97

Click cells to compare fundamentals

Integral Diagnostics Account Relationship Matchups

Integral Diagnostics income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Interest Expense	8.6M	8.8M	10.5M	18.3M	22.3M	23.4M
Total Revenue	274.1M	348.8M	358.7M	440.1M	469.7M	238.8M
Operating Income	38.4M	47.9M	38.4M	40.1M	5.4M	5.1M
Income Before Tax	35.3M	45.2M	22.7M	31.0M	(57.1M)	(54.2M)
Depreciation And Amortization	25.7M	34.9M	36.7M	43.5M	47.1M	49.5M
Selling General Administrative	161.2M	207.6M	227.0M	285.6M	305.8M	162.8M
Gross Profit	72.1M	92.2M	83.8M	97.8M	103.8M	74.0M
Other Operating Expenses	235.7M	300.9M	320.3M	400.0M	469.7M	493.2M
Ebit	43.8M	54.0M	33.2M	49.3M	(34.8M)	(33.0M)
Ebitda	69.5M	88.9M	69.9M	92.7M	12.3M	11.7M
Total Operating Expenses	33.7M	44.3M	45.4M	57.6M	61.9M	43.6M
Net Income	23.0M	31.3M	14.6M	25.0M	(60.7M)	(57.7M)
Income Tax Expense	12.2M	14.0M	8.0M	5.6M	3.6M	7.1M
Net Income From Continuing Ops	23.0M	31.3M	14.6M	25.0M	(60.7M)	(57.7M)
Cost Of Revenue	202.0M	256.6M	274.9M	342.3M	365.9M	201.2M
Total Other Income Expense Net	(3.1M)	(9.0M)	(13.7M)	(8.5M)	(62.4M)	(59.3M)
Net Income Applicable To Common Shares	23.0M	31.3M	14.6M	25.0M	28.8M	18.1M
Tax Provision	12.2M	14.0M	8.0M	5.6M	3.6M	3.4M
Interest Income	7.9M	88K	39K	18.2M	861K	818.0K
Net Interest Income	(8.6M)	(8.8M)	(10.4M)	(17.9M)	(21.7M)	(20.6M)
Selling And Marketing Expenses	127.5M	163.2M	179.4M	227.3M	243.9M	165.4M
Reconciled Depreciation	25.7M	34.9M	36.7M	43.5M	46.9M	30.3M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Integral Stock Analysis

When running Integral Diagnostics' price analysis, check to measure Integral Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integral Diagnostics is operating at the current time. Most of Integral Diagnostics' value examination focuses on studying past and present price action to predict the probability of Integral Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integral Diagnostics' price. Additionally, you may evaluate how the addition of Integral Diagnostics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC